Trial record 1 of 1 for:    R668-AD-0914
Previous Study | Return to List | Next Study

Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01259323
Recruitment Status : Completed
First Posted : December 14, 2010
Last Update Posted : October 4, 2012
Information provided by (Responsible Party):
Regeneron Pharmaceuticals